期刊文献+

外磁场下磁性纳米C3转移酶载体在大鼠损伤脊髓中的分布 被引量:2

Target distribution of magnetic nano C3-transferase carrier under external magnetic field in injured spinal cord in rats
下载PDF
导出
摘要 目的:观察施加外磁场后磁性纳米C3转移酶药物载体(简称载药微球)在大鼠损伤脊髓局部的分布情况,并观察不同时间作用的外磁场对该载体分布的影响。方法:构建载药微球,检测其粒径、Zeta电位,透射电镜观察形态、测定磁场顺应性及药物释放;MTT法测定其细胞毒性;观察体外培养条件下细胞的摄取情况。82只大鼠建立T10损伤模型(NYU法),随机分为5组:A组,经尾静脉注射异硫氰酸荧光素组,20只;B组,经尾静脉注射载药微球组,20只;C组,经尾静脉注射载药微球+外磁场15min组,20只;D组,经尾静脉注射载药微球+外磁场30min组,12只;E组,经尾静脉注射载药微球+外磁场1h组,10只。A、B、C组各取10只大鼠,经尾静脉注射1h后,取肝、肾、脾及T10为中心的脊髓组织做冰冻切片并观察载药微球在其中的分布;5组各10只大鼠经尾静脉注射1h后取T10为中心4cm脊髓组织,火焰原子吸收分光光度法测定铁含量;D组取2只大鼠,电镜观察载药微球在脊髓组织中分布。结果:载药微球分散性好,载药微球磁化强度饱和度值为63.5emu/g,载药微球缓慢释放药物且释药时间超过9d,载药微球与细胞共培养,细胞平均存活率为78.10%,与细胞共培养5s后能够在细胞内达到良好聚集效果。C组脊髓损伤中心荧光强度高于A、B组。C组脊髓铁元素含量高于A、B组,D组测定铁含量高于C组(P<0.05),E组测定铁含量高于C组(P<0.05),D组测定铁含量与E组无统计学意义(P>0.05)。电镜观察载药微球聚集在损伤中心,可进入神经细胞胞体内。结论:磁性纳米C3转移酶药物载体可靶向聚集在损伤区局部,载药微球可进入脊髓损伤区神经细胞内;损伤后施加外磁场30min,载药微球可达到最佳聚集效果。 Objectives: To observe the target distribution of magnetic nano C3-transferase carrier under external magnetic field in injured spinal cord and explore this time-related effect.Methods: Drug carrier microsphere was constructed;the particle size,zeta potential,magnetic properties,drug release were assessed;the morphology was observed by transmission electron microscopy;the in vitro cytotoxicity was tested either;and the cellular uptake was analyzed using fluorescence microscopy.Eight-two SCI rats were divided into 5 groups randomly: Group A(n=20),fluorescein isothiocyanate group(FITC) administered by caudal vein,20 rats;Group B(n=20),drug carrier microsphere administered by caudal vein;Group C(n=20),drug carrier microsphere administered by caudal vein and external magnetic 15min;Group D(n=12),drug carrier microsphere administered by caudal vein and external magnetic 30min;Group E(n=10),drug carrier microsphere administered by caudal vein and external magnetic 1h.10 rats in Group A,B and C respectively were selected,and the tissues including liver,kindey,spleen and T10 spinal cord were harvested 1h after administration by caudal vein,then the liposome distribution in these tissues was observed under fluorescence microscopy.10 rats in Group A,B,C,D and E respectively were sacrificed and the T10 spinal cord was harvested 1h after administration by caudal vein,and the iron contents were assayed by flame atomic absorption spectrophotometry.2 rats in Group D sacrificed and the T10 spinal cord was harvested 1h after administration by caudal vein,and the distribution of drug carrier microsphere was observed under electron microscope.Results: Drug carrier microspheres showed good dispersion,with the saturation value of magnetization of 63.5emu g,and the carrier could maintain drug realease in vitro until day 9;when co-culturing with MCF-7 cells,the average cell survival rate was 78.10%;FITC fluorescence density of Group C in injured center was more than group A and B.The iron contents in spinal cord of Group C showed significant difference than Group A and B(P〈0.05),and those in group E were more than group C(P〈0.05),while those in group D showed no difference than group C.The carriers were noted gathering in the center of injury and into neurocyte under electron microscopy.Conclusions: Magnetic nano C3-transferase drug carriers can accumulate into injured site of spine cord and enter neurocyte;adding external magnetic field of 30min after SCI can achieve optimal effect for aggregation.
出处 《中国脊柱脊髓杂志》 CAS CSCD 北大核心 2012年第3期265-271,共7页 Chinese Journal of Spine and Spinal Cord
基金 国家自然科学基金(30872603)
关键词 脊髓损伤 药物载体 靶向 大鼠 C3转移酶 Spinal cord injury Drug carrier Targeting Rat
  • 相关文献

参考文献14

  • 1Garbuzova-Davis S,Haller E,Saporta S,et al.Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS[J].Brain Research,2007,1157:126-137.
  • 2刘晓谦,王锦玉,仝燕,王智民.脂质体制备技术及其研究进展[J].中国药学杂志,2011,46(14):1084-1088. 被引量:34
  • 3Tan EY,Law JW,Wang CH,et al.Development of a cell tra-nsducible RhoA inhibitor TAT-C3 transferase and its en-capsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons[J].Pharm Res,2007,24(12):2297-2308.
  • 4Fu Q,Hue J,Li S.Nonsteroidal anti-inflammatory drugs pro-mote axon regeneration via rhoA inhibition[J].J Neurosci,2007,27(15):4154-4164.
  • 5Lord-Fontaine S,Yang F,Diep Q,et al.Local inhibition of rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury[J].J Neurotrauma,2010,25(11):1309-1322.
  • 6Boato F,Hendrix S,Huelsenbeck SC,et al.C3 peptide en-hances recovery from spinal cord injury by improved regener-ative growth of descending fiber tracts[J].J Cell Sci,2010,123(10):1652-1662.
  • 7SIKIRIC′M,BRAJENOVIC′N,PAVLOVIC′I,et al.The determination of metals in cow′s milk by flame atomic ab-sorption spectrophotometry[J].Czech J Anim Sci,2003,48(11):481-486.
  • 8Jeffery ND,McBain SC,Dobson J,et al.Uptake of systemically administered magnetic nanoparticles in areas of experimental spinal cord injury[J].J Tissue Eng Regen Med,2009,3(2):153-157.
  • 9Liu Y,Wang CY,Feng SQ,et al.Ability of novel multifunc-tional PEG-TAT-modified liposomes to cross the blood-spinal cord barrier after spinal cord injury[J].J Drug Target,2010,16(6):420-429.
  • 10Cho Y,Shi R,Borgens RB.Chitosan produces potent neuro-protection and physiological recovery following traumatic spinal cord injury[J].J Exp Biol,2010,213(9):1513-1520.

二级参考文献69

  • 1徐华,宋涛.磁性药物靶向治疗中磁流体的体外动力学研究[J].北京生物医学工程,2005,24(3):204-208. 被引量:9
  • 2KIM S, TURKER M S,CHI E Y,et al. Preparation of muhivesicular liposomes [ J ]. Biochim Biophys Acta, 1983,728 ( 3 ) : 339-348.
  • 3ALLEN T M,HANSEN C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose [ J ]. Biochem Biophys Acta, 1991,1068(2) : 133-141.
  • 4MOURTAS S, DURAJ S, FOTOPOULOU S, et al. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels[ J]. Colloid SugCace B, 2008,61 (2) : 270-276.
  • 5BATZRI S, KORN E D. Single bilayer liposomes prepared without sonication[J]. Biochim Biophys Acta, 1973,298 ( 4 ) : 10151019.
  • 6MAITANI Y, IGARASHI S, SATO M, et al. Cationic liposome (DC-Chol/DOPE = 1:2)and a modified ethanol injection method to prepare liposomes, increased gene expression [ J ]. Inter J Pharm,2007,342(1-2) : 33-39.
  • 7FAN M H, XU S Y, XIA S Q, et al. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study[J]. Eur Food Res Technol,2008,227( 1 ) : 167-174.
  • 8WAGNER A, VORAUER-UHL K, KREISMAYR G, et al. The cmssflow injection technique : An improvement of the ethanol injection method[J]. J Liposome Res,2002,12(3) : 259-270.
  • 9STACHOWIAK J C, RICHMOND D L, THOMAS H L, et al. Inkjet formation of unilamellar lipid vesicles for cell-like encapsulation[J]. Lab Chip,2009,9(14) : 2003-2009.
  • 10SAKAI H, GOTOH T, IMURA T, et al. Preparation and properties of liposomes composed of various phospholipids with different hydrophobic chains using a supercritical reverse phase evaporation method[J]. J Oleo Sci,2008,57( 11): 613-621.

共引文献36

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部